Capnerve P 1500mcg/75mg Tablet SR
Marketer
Capcure Pharmaceuticals
Salt Composition
Methylcobalamin (1500mcg) + Pregabalin (75mg)
Overview Capnerve P 1500mcg/75mg Tablet SR
Pregabalin-N 1500mcg/75mg Extended-Release Tablets are a prescription medication managing neuropathic pain. Its mechanism involves modulating nerve cell calcium channels to reduce pain signals. This medication also offers neuroprotective effects and facilitates nerve cell repair. Take Pregabalin-N orally, with or without food, ideally at bedtime, consistently each day for stable blood levels. Follow your physician's dosage and duration instructions precisely, as this medication can be habit-forming. If a dose is missed, take it immediately upon recall. Complete the entire course of therapy, even with symptom improvement. Abrupt cessation requires prior consultation with your doctor. Commonly reported side effects include upper respiratory infection, increased appetite, elevated mood, tremors, visual blurring, dry mouth, vertigo, and somnolence. Refrain from activities demanding concentration until the medication's effects are known. Side effects are generally mild and tend to lessen over time. Weight gain is possible; regular exercise and a balanced diet are recommended for management. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor immediately. Disclose all other medications to your physician, as interactions may reduce efficacy or alter the drug's action. Notify your doctor if you are pregnant, considering pregnancy, or breastfeeding.
Primary Ingredients of Capnerve P 1500mcg/75mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Capnerve P 1500mcg/75mg Tablet SR
Managing neuropathic pain
Major Benefits of Capnerve P 1500mcg/75mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Capnerve P 1500mcg/75mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable; however, consistent daily timing is recommended.
Common Side effects of Capnerve P 1500mcg/75mg Tablet SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Capnerve P 1500mcg/75mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Capnerve P 1500mcg/75mg Sustained-Release Tablet can be consumed with or without food, although consistent daily timing is recommended.
How Capnerve P 1500mcg/75mg Tablet SR works:
Capnerve P 1500mcg/75mg Extended-Release Tablets contain methylcobalamin and pregabalin, working synergistically to alleviate neuropathic pain. Methylcobalamin, a vitamin B12 derivative, supports myelin sheath formation and repair, protecting nerve fibers. Pregabalin, an alpha-2-delta calcium channel ligand, reduces pain signaling by modulating calcium influx into nerve cells. This combined action offers effective relief from nerve damage-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Capnerve P 1500mcg/75mg sustained-release tablets and alcohol can result in significant sedation.
PregnancyCONSULT YOUR DOCTOR
Use of Capnerve P 1500mcg/75mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against potential hazards before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Capnerve P tablets (1500 mcg/75 mg) are likely unsafe for breastfeeding mothers. Available human data indicate potential drug transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Capnerve P 1500mcg/75mg SR tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving while experiencing these effects.
KidneyCAUTION
Patients with kidney impairment should use Capnerve P 1500mcg/75mg sustained-release tablets cautiously. Dosage modification for Capnerve P 1500mcg/75mg sustained-release tablets might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Capnerve P 1500mcg/75mg SR tablets in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary, though further data is limited. Physician consultation is advised.
What if you forget to take Capnerve P 1500mcg/75mg Tablet SR :
Should you forget a Capnerve P 1500mcg/75mg SR Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Capnerve P 1500mcg/75mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Neuroscience and Central Nervous System |
3,018 People bought this recently